188 related articles for article (PubMed ID: 24443403)
1. Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II.
Graff RE; Cho E; Lindström S; Kraft P; Willett WC; Eliassen AH
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):516-24. PubMed ID: 24443403
[TBL] [Abstract][Full Text] [Related]
2. Hemochromatosis gene mutations, body iron stores, dietary iron, and risk of colorectal adenoma in women.
Chan AT; Ma J; Tranah GJ; Giovannucci EL; Rifai N; Hunter DJ; Fuchs CS
J Natl Cancer Inst; 2005 Jun; 97(12):917-26. PubMed ID: 15956653
[TBL] [Abstract][Full Text] [Related]
3. Plasma ferritin levels, HFE polymorphisms, and risk of pancreatic cancer among Chinese Han population.
Zhao Z; Li C; Hu M; Li J; Liu R
Tumour Biol; 2014 Aug; 35(8):7629-33. PubMed ID: 24798971
[TBL] [Abstract][Full Text] [Related]
4. Plasma Anti-Müllerian Hormone Concentrations and Risk of Breast Cancer among Premenopausal Women in the Nurses' Health Studies.
Eliassen AH; Zeleniuch-Jacquotte A; Rosner B; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2016 May; 25(5):854-60. PubMed ID: 26961996
[TBL] [Abstract][Full Text] [Related]
5. Plasma ferritin levels, genetic variations in HFE gene, and coronary heart disease in Chinese: a case-control study.
Shi Y; Zhou L; Huang LH; Lian YT; Zhang XM; Guo H; Wu TC; Cheng LX; He MA
Atherosclerosis; 2011 Oct; 218(2):386-90. PubMed ID: 21696736
[TBL] [Abstract][Full Text] [Related]
6. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.
Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE
Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468
[TBL] [Abstract][Full Text] [Related]
7. A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis.
Constantine CC; Anderson GJ; Vulpe CD; McLaren CE; Bahlo M; Yeap HL; Gertig DM; Osborne NJ; Bertalli NA; Beckman KB; Chen V; Matak P; McKie AT; Delatycki MB; Olynyk JK; English DR; Southey MC; Giles GG; Hopper JL; Allen KJ; Gurrin LC
Br J Haematol; 2009 Oct; 147(1):140-9. PubMed ID: 19673882
[TBL] [Abstract][Full Text] [Related]
8. Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II.
Eliassen AH; Spiegelman D; Hollis BW; Horst RL; Willett WC; Hankinson SE
Breast Cancer Res; 2011 May; 13(3):R50. PubMed ID: 21569367
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
[TBL] [Abstract][Full Text] [Related]
10. Associations of common variants in HFE and TMPRSS6 with iron parameters are independent of serum hepcidin in a general population: a replication study.
Galesloot TE; Geurts-Moespot AJ; den Heijer M; Sweep FC; Fleming RE; Kiemeney LA; Vermeulen SH; Swinkels DW
J Med Genet; 2013 Sep; 50(9):593-8. PubMed ID: 23794717
[TBL] [Abstract][Full Text] [Related]
11. Premenopausal plasma carotenoids, fluorescent oxidation products, and subsequent breast cancer risk in the nurses' health studies.
Sisti JS; Lindström S; Kraft P; Tamimi RM; Rosner BA; Wu T; Willett WC; Eliassen AH
Breast Cancer Res Treat; 2015 Jun; 151(2):415-25. PubMed ID: 25917867
[TBL] [Abstract][Full Text] [Related]
12. CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients.
Pelucchi S; Mariani R; Calza S; Fracanzani AL; Modignani GL; Bertola F; Busti F; Trombini P; Fraquelli M; Forni GL; Girelli D; Fargion S; Specchia C; Piperno A
Haematologica; 2012 Dec; 97(12):1818-25. PubMed ID: 22773607
[TBL] [Abstract][Full Text] [Related]
13. Plasma enterolactone and breast cancer risk in the Nurses' Health Study II.
Xie J; Tworoger SS; Franke AA; Terry KL; Rice MS; Rosner BA; Willett WC; Hankinson SE; Eliassen AH
Breast Cancer Res Treat; 2013 Jun; 139(3):801-9. PubMed ID: 23760859
[TBL] [Abstract][Full Text] [Related]
14. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent ferritin elevations and HFE C282Y mutation as risk factors for symptomatic knee osteoarthritis in males: a longitudinal cohort study.
Kennish L; Attur M; Oh C; Krasnokutsky S; Samuels J; Greenberg JD; Huang X; Abramson SB
BMC Musculoskelet Disord; 2014 Jan; 15():8. PubMed ID: 24401005
[TBL] [Abstract][Full Text] [Related]
16. Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer.
Shaheen NJ; Silverman LM; Keku T; Lawrence LB; Rohlfs EM; Martin CF; Galanko J; Sandler RS
J Natl Cancer Inst; 2003 Jan; 95(2):154-9. PubMed ID: 12529348
[TBL] [Abstract][Full Text] [Related]
17. Red meat intake and risk of breast cancer among premenopausal women.
Cho E; Chen WY; Hunter DJ; Stampfer MJ; Colditz GA; Hankinson SE; Willett WC
Arch Intern Med; 2006 Nov; 166(20):2253-9. PubMed ID: 17101944
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
[TBL] [Abstract][Full Text] [Related]
19. C282Y polymorphism in the HFE gene is associated with risk of breast cancer.
Liu X; Lv C; Luan X; Lv M
Tumour Biol; 2013 Oct; 34(5):2759-64. PubMed ID: 23681799
[TBL] [Abstract][Full Text] [Related]
20. Iron stores and HFE genotypes are not related to increased risk of ischemic stroke. A prospective nested case-referent study.
Ekblom K; Hultdin J; Stegmayr B; Johansson I; Van Guelpen B; Hallmans G; Weinehall L; Johansson L; Wiklund PG; Marklund SL
Cerebrovasc Dis; 2007; 24(5):405-11. PubMed ID: 17878720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
